(Reuters) – Moderna (NASDAQ:) Inc will join the as of the start of trading on July 21, replacing Alexion Pharmaceuticals (NASDAQ:), S&P Dow Jones Indices said in a statement on Thursday.
Moderna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker’s stock has surged over 150% this year, elevating its market capitalization to about $100 billion.
Britain’s AstraZeneca (NASDAQ:) said last December it would acquire U.S. biotech Alexion in a $39 billion deal.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.